---
figid: PMC5365005__MMR-15-04-1461-g05
figtitle: Sclareolide pathway enhances gemcitabine-induced gemcitabine-resistant human
  pancreatic cancer cell death
organisms:
- NA
pmcid: PMC5365005
filename: MMR-15-04-1461-g05.jpg
figlink: /pmc/articles/PMC5365005/figure/f6-mmr-15-04-1461/
number: F6
caption: Sclareolide pathway enhances gemcitabine-induced gemcitabine-resistant human
  pancreatic cancer cell death. HPCCs became GR-HPCCs due to the activation of NICD
  and Gli1. Inhibition of hENT1 and activation of RRM1 contributed to gemcitabine
  resistance. NICD and Gli1 can activated TWIST1 and Slug, which contributed to EMT.
  Sclareolide inhibited these alterations. GR-HPCCs, gemcitabine-resistant human pancreatic
  cancer cells; NICDl, NOTCH1 intracellular cytoplasmic domain; Gli1, glioma-associated
  oncogene 1; hENT1, human equilibrative nucleoside transporter 1; RRM1, ribonucleoside
  diphosphate reductase 1; EMT, epithelial to mesenchymal transition.
papertitle: Sclareolide enhances gemcitabine-induced cell death through mediating
  the NICD and Gli1 pathways in gemcitabine-resistant human pancreatic cancer.
reftext: Sheng Chen, et al. Mol Med Rep. 2017 Apr;15(4):1461-1470.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8445247
figid_alias: PMC5365005__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5365005__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5365005__MMR-15-04-1461-g05.html
  '@type': Dataset
  description: Sclareolide pathway enhances gemcitabine-induced gemcitabine-resistant
    human pancreatic cancer cell death. HPCCs became GR-HPCCs due to the activation
    of NICD and Gli1. Inhibition of hENT1 and activation of RRM1 contributed to gemcitabine
    resistance. NICD and Gli1 can activated TWIST1 and Slug, which contributed to
    EMT. Sclareolide inhibited these alterations. GR-HPCCs, gemcitabine-resistant
    human pancreatic cancer cells; NICDl, NOTCH1 intracellular cytoplasmic domain;
    Gli1, glioma-associated oncogene 1; hENT1, human equilibrative nucleoside transporter
    1; RRM1, ribonucleoside diphosphate reductase 1; EMT, epithelial to mesenchymal
    transition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLI1
  - SNAI2
  - SLC29A1
  - RRM1
  - TWIST1
  - ITK
  - SLC22A3
  - Gemcitabine
  - Sclareolide
---
